Loading…
Reported covered position: Chief of Staff, Leg. Director & Staff Assist. to Sen. Chris Dodd, and Prof. Staff Member of Senate HELP Subcommittee on Children & Families, Chaired by Sen. Dodd (1996-2011)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EXELIXIS INC. via EXELIXIS INC.
2026 · third_quarter · Q3
Federal tax policy issues affecting the biopharmaceutical industry, including provisions related to business taxation, research and development incentives, and broader fiscal legislation.
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Source: Senate LDA
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Federal Contractor Cybersecurity Vulnerability Reduction Act of 2024
Client: EXELIXIS INC. · Firm: EXELIXIS INC.
Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.5028, The Small Business Biotech Act.
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Policies and proposals related to drug pricing, including HR 3 (Elijah E Cummings Lower Drug Costs Now Act); and administration of the 340B Program.
Policies and proposals related to drug pricing, including HR 3 (Elijah E Cummings Lower Drug Costs Now Act); and administration of the 340B Program.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2026 · second_quarter · Q2
Proposals related to drug pricing, including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, to include CMMIs GUARD and GLOBE models, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels. Development and implementation of national security policies impacting biotechnology, including regulatory frameworks that may affect cross-border investments, research collaborations, and business operations
Federal tax policy issues affecting the biopharmaceutical industry, including provisions related to business taxation, research and development incentives, and broader fiscal legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2026 · first_quarter · Q1
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · third_quarter · 3A
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · fourth_quarter · 4A
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · fourth_quarter · Q4
IRC Section 174 amortization of R&D expenditures.
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · third_quarter · Q3
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · second_quarter · Q2
Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2025 · first_quarter · Q1
Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. Reintroduction of the Small Biotech Innovation Act. Health agency funding levels.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2024 · fourth_quarter · Q4
IRC Section 174 amortization of R&D expenditures
Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.5028, The Small Business Biotech Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2024 · third_quarter · Q3
IRC Section 174 amortization of R&D expenditures
Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2024 · second_quarter · Q2
Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act.
IRC Section 174 amortization of R&D expenditures
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2024 · first_quarter · Q1
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act.
IRC Section 174 amortization of R&D expenditures
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2023 · fourth_quarter · Q4
IRC Section 174 amortization of R&D expenditures
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2023 · third_quarter · Q3
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act.
IRC Section 174 amortization of R&D expenditures
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2023 · second_quarter · Q2
IRC Section 174 amortization of R&D expenditures
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EXELIXIS INC. via EXELIXIS INC.
2023 · first_quarter · Q1
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program.
IRC Section 174 amortization of R&D expenditures
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2022 · fourth_quarter · Q4
Policies and proposals related to drug pricing, including provisions of the Inflation Reduction Act; and administration of the 340B Program.
IRC Section 174 amortization of R&D expenditures.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2022 · third_quarter · Q3
Policies and proposals related to drug pricing, including provisions of the Inflation Reduction Act; and administration of the 340B Program.
IRC Section 174 amortization of R&D expenditures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2022 · second_quarter · Q2
America COMPETES Act (provision concerning IRC Section 174 amortization rules)
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2022 · first_quarter · Q1
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2021 · fourth_quarter · Q4
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2021 · third_quarter · Q3
Policies and proposals related to drug pricing, including HR 3 (Elijah E Cummings Lower Drug Costs Now Act); and administration of the 340B Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2021 · second_quarter · Q2
Policies and proposals related to drug pricing, including HR 3 (Elijah E Cummings Lower Drug Costs Now Act); and administration of the 340B Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2021 · first_quarter · Q1
Policies and proposals related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2020 · fourth_quarter · Q4
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2020 · third_quarter · Q3
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2020 · second_quarter · Q2
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2020 · first_quarter · Q1
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2019 · fourth_quarter · Q4
HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2019 · third_quarter · Q3
The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019 and issues related to pharmaceutical access and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2019 · second_quarter · Q2
The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019 and issues related to pharmaceutical access and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2019 · first_quarter · Q1
Issues related to pharmaceutical access and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS INC. via EXELIXIS INC.
2019 · first_quarter · RR
Issues relating to pharmaceutical pricing